CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 27 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,505,000 | +11.1% | 3,606,707 | 0.0% | 0.87% | +44.3% |
| Q4 2021 | $10,351,000 | -27.7% | 3,606,707 | 0.0% | 0.60% | -28.7% |
| Q3 2021 | $14,319,000 | -33.4% | 3,606,707 | 0.0% | 0.85% | -31.6% |
| Q2 2021 | $21,496,000 | -50.9% | 3,606,707 | 0.0% | 1.24% | -52.9% |
| Q1 2021 | $43,785,000 | -16.8% | 3,606,707 | 0.0% | 2.63% | -16.0% |
| Q4 2020 | $52,622,000 | +26.8% | 3,606,707 | 0.0% | 3.13% | +1.8% |
| Q3 2020 | $41,513,000 | – | 3,606,707 | – | 3.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|